(Q36458364)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

NK1 receptor antagonists under investigation for the treatment of affective disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Eberhard Fuchs

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mária Simon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Investigational Drugs

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

479-486

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

An unidentified depressor substance in certain tissue extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Do substance P and the NK1 receptor have a role in depression and anxiety?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Substance P stimulates inhibitory synaptic transmission in the guinea pig basolateral amygdala in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Activation of neurokinin-1 receptors promotes GABA release at synapses in the rat entorhinal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Action of tachykinins in the rat hippocampus: modulation of inhibitory synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Chronic stress decreases the number of parvalbumin-immunoreactive interneurons in the hippocampus: prevention by treatment with a substance P receptor (NK1) antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: ([18F]SPA-RQ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

The cellular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

The neurobiology of stress: from serendipity to clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Depression: a case of neuronal life and death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Neurogenesis and depression: etiology or epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Examining SLV-323, a novel NK1 receptor antagonist, in a chronic psychosocial stress model for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Substance P serum levels are increased in major depression: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Serum levels of substance P and response to antidepressant pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Substance P in serum and cerebrospinal fluid of depressed patients: no effect of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Neurokinin-1 receptors are decreased in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Lower hippocampal volume in patients suffering from depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.5.479

10.1517/13543784.15.5.479

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16634686%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference